Autoimmune hepatitis complicated by adult-onset Still’s disease during
treatment with tocilizumab: a case report from acute onset to recurrence
- Daiki Uchihara
, - Tomohiro Suzuki,
- Yudai Koya,
- Mayumi Tai,
- Osamu Ichii,
- Nobuo Matsuhashi,
- Yutaka Ejiri,
- Tomoya Kato,
- Yuichi Honma,
- Michihiko Shibata,
- Masaru Harada
Yudai Koya
University of Occupational and Environmental Health Japan
Author ProfileYuichi Honma
University of Occupational and Environmental Health Japan
Author ProfileMichihiko Shibata
University of Occupational and Environmental Health Japan
Author ProfileMasaru Harada
University of Occupational and Environmental Health Japan
Author ProfileAbstract
Differentiating autoimmune hepatitis from liver dysfunction due to
adult-onset Still's disease is important in deciding whether to
terminate or continue corticosteroid therapy, and also in terms of
management of cirrhosis and surveillance of hepatocellular carcinoma.
Liver biopsy is thought to be the most important determinant for
differential diagnosis.14 Feb 2023Submitted to Clinical Case Reports 16 Feb 2023Submission Checks Completed
16 Feb 2023Assigned to Editor
21 Feb 2023Reviewer(s) Assigned
28 Feb 2023Review(s) Completed, Editorial Evaluation Pending
15 Mar 2023Editorial Decision: Revise Minor
12 Apr 20231st Revision Received
28 Apr 2023Submission Checks Completed
28 Apr 2023Assigned to Editor
28 Apr 2023Review(s) Completed, Editorial Evaluation Pending
01 Jun 2023Editorial Decision: Accept
